fbpx

Brain Cancer-Malignant Glioma- The Burzynski Research Institute

Share Button

We report a 44-year-old female with a recurrent, multicentric, malignant glioma who experienced a durable remission lasting more than four years…

The study linked below documents a case of “44-year-old female with a recurrent, multicentric, malignant glioma-“anaplastic astrocy-toma (WHO Grade III).”” This women underwent both conventional chemotherapy and radiation. Her brain cancer continued to grow and spread. She then underwent “sodium phenylbutyrate” and then acheived a 4-year remission as of the writing of this article.

After several years of conventional therapies for my blood cancer, multiple myeloma, I reached “end-stage” by 9/97. I underwent antineoplaston therapy (ANP) from 11/3/97-4/3/99. ANP therapy offers a viable therapy option for those who’s cancer diagnoses are problematic.

Burzynski and ANP therapy is controversial to say the least. I can say without a doubt that ANP put me into complete remission where I remain today.

Glioblastoma Multiforme (GBM) is an aggressive form of brain cancer that conventional oncology has difficulty treating. There are a number of non-conventional therapies written about on PeopleBeatingCancer that offer real hope for the GBM patient.

I a both a cancer survivor and cancer coach. For more information about conventional, integrative and non-conventional GBM therapies scroll down the page, post a question or comment and I will reply ASAP.

thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Recommended Reading:


Complete response of a recurrent, multicentric malignant glioma in a patient treated with phenylbutyrate.

“Sodium phenylbutyrate is a biological-response modifier that acts as a dose-dependent inhibitor of glioma cell proliferation, migration, and invasiveness in vitro, possibly by inhibition of urokinase and c-myc pathways. Despite its biological activity in vitro, there have not been any prior reports of efficacy in the treatment of human malignant gliomas. We report a 44-year-old female with a recurrent, multicentric, malignant glioma who experienced a durable remission lasting more than four years…

The patient was started on sodium phenylbutyrate, 18 g daily in three divided oral doses, and reduced to 9 g/day and eventually to 4.5 g/day to eliminate mild, reversible side effects.

Four years later, the patient has a KPS functional score of 100%. Phenylbutyrate is a well-tolerated, oral agent that shows potential for the treatment of malignant gliomas…”

 

 

Leave a Comment:

5 comments
Vaccines and "Out of the Box" Therapies for Brain Cancer - PeopleBeatingCancer says a couple of years ago

[…] Brain Cancer-Malignant Glioma- The Burzynski Research Institute […]

Reply
Gisella says 4 years ago

I have questions about treatment at the clinic. Can you please email me privately? Thank you

Reply
    David Emerson says 4 years ago

    I just emailed you privately-

    David

    Reply
Emel says 5 years ago

Is it difficult to get treatment at the Burzynski medical center ?

Reply
    David Emerson says 5 years ago

    Emel-

    In response to your question “Is it difficult to get treatment at the Burzynski medical center?” no, it is not difficult. As a former patient I think there are several pros and cons of treatment with antineoplastons. What kind of cancer have you been diagnosed with?

    David Emerson
    MM survivor
    MM cancer coach

    Reply
Add Your Reply